EANS-Adhoc: The Board of Directors of LifeWatch rejects the candidates for its Board proposed by a group of shareholders (with document)

--------------------------------------------------------------------------------
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
distribution. The issuer is solely responsible for the content of this
announcement.
--------------------------------------------------------------------------------

Company Information/LifeWatch AG

15.06.2012

Neuhausen am Rheinfall/Switzerland - The Board of Directors of
LifeWatch AG (SIX Swiss Exchange: LIFE) rejects the candidates
proposed by a shareholder group due to missing specific track records
in the relevant industries or markets and recommends to the
shareholders of LifeWatch to vote against these candidates but to
follow the motions proposed by the Board of directors.

You will find a PDF-version at the end of this message.

The Board of Directors of LifeWatch acknowledged the wish of the
shareholder group to be represented in the Board of Directors
adequately according to their shareholding. For this very purpose we
included 5 "Election of one (1) new Member of the Board of Directors"
in the agenda of the General Meeting. The Board invited the group on
several occasions to propose a suitable candidate for a seat on the
Board and to say whether the candidate would accept the necessary
regulatory and legal conditions regarding the representation of the
shareholder group on the Board.

In addition to Patrick Schildknecht the shareholder group proposed
two other candidates from Germany named Dr. Wolfgang Reim and Dr.
Thomas Rühle. The Board is fully acknowledging their personal track
records. However, all candidates suffer from a missing track record
in our relevant industry or additional experience in (new) target
markets. Furthermore the Board has to deplore about a lack of a due
process for the nomination of candidates as none of these candidates
has ever sent a detailed CV or other background material to the
attention of the Board. Consequently, the Board of LifeWatch
recommends to the Shareholders of LifeWatch AG to not support any of
these candidates and as a consequence, the motion of the Board is to
vote against these candidates if presented under agenda item 5
"Election of one (1) new member of the Board of Directors."

In summer 2011, the company developed a new strategy with an
internationally reputed consulting firm, which is now being
implemented step by step, to diversify into new geographic markets
and service areas. The company has already launched or announced new
products and services into these technologically demanding and highly
competitive markets, including the world's first-of-its-kind global
smart phone health care solution.

The new strategy should be implemented successfully and
systematically by a management team with proven expertise. Therefore
the current management team will be strengthened across all levels
including top management. Although it is demanding and time consuming
to find and win top talents for a small company like LifeWatch in a
fast-moving market we are now carrying out this process with utmost
resolve, care and responsibility for the company's prospects. The
Board of LifeWatch AG recommends to the shareholders of LifeWatch to
vote in favour for the motions of the Board at the upcoming AGM and
to create clarity with their vote.

About LifeWatch AG:

LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on
SIX Swiss Exchange (LIFE), Switzerland, is the leading healthcare
technology and solution company, specializing in advanced telehealth
systems and wireless remote patient monitoring services. LifeWatch
services cater to individuals, ranging from high-risk and chronically
ill patients, to consumers of health and wellness products. LifeWatch
has subsidiaries in the United States, the Netherlands, Japan, the
United Kingdom, Switzerland and Israel. LifeWatch AG is the parent
company of LifeWatch Services Inc., a leading US-based cardiac
monitoring service provider, and manufacturer of telecardiology
products. LifeWatch is also introducing a new program for Home Sleep
Testing of Obstructive Sleep Apnea (OSA) patients under the brand
name NiteWatch. For additional information, please visit
www.lifewatch.com.

E-Mail Alerts: Sign-up for customized E-mail alerts and documentation
requests is available at
http://production.investis.com/lifewatch/alert-service/

This press release includes forward-looking statements. All
statements other than statements of historical facts contained in
this press release, including statements regarding future results of
operations and financial position, business strategy and plans and
objectives for future operations, are forward-looking statements. The
words "believe," "may," "will," "estimate," "continue,""anticipate,"
"intend," "expect" and similar expressions are intended to identify
forward-looking statements. LifeWatch AG has based these
forward-looking statements largely on current expectations and
projections about future events and financial trends that it believes
may affect the financial condition, results of operations, business
strategy, short term and long term business operations and
objectives, and financial needs. These forward-looking statements are
subject to a number of risks, uncertainties and assumptions. In light
of these risks, uncertainties and assumptions, the forward-looking
events and circumstances described may not occur and actual results
could differ materially and adversely from those anticipated or
implied in the forward-looking statements. All forward-looking
statements are based only on data available to LifeWatch AG at the
time of the issue of this press release. LifeWatch AG does not
undertake any obligation to update any forward-looking statements
contained in this press release as a result of new information,future
events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF
AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR
PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS
PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH
AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN
INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH
AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN
REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE
OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S.
PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY
PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE
MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG
OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED
INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL
STATEMENTS OF THE ISSUER.

Attachments with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/oRuLxHhe

Further inquiry note:
Sensus Investor and Public Relations, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12
Email lifewatch@sensus.ch

end of announcement euro adhoc
--------------------------------------------------------------------------------

Attachments with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/oRuLxHhe

issuer: LifeWatch AG
Rundbuckstrasse 6
CH-8212 Neuhausen am Rheinfall
phone: +41 52 632 00 50
FAX: +41 52 632 00 51
mail: users@lifewatch.com
WWW: www.lifewatch.com
sector: Healthcare Providers
ISIN: CH0012815459
indexes: SPI, SPIEX
stockmarkets: free trade: Berlin, Open Market / XETRA: Frankfurt, Main Standard:
SIX Swiss Exchange
language: English